SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-001895
Filing Date
2023-01-06
Accepted
2023-01-06 16:56:58
Documents
14
Period of Report
2023-01-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm232529d1_8k.htm   iXBRL 8-K 35900
2 EXHIBIT 99.1 tm232529d1_ex99-1.htm EX-99.1 9925
6 GRAPHIC tm232529d1_ex99-1img001.jpg GRAPHIC 5141
  Complete submission text file 0001104659-23-001895.txt   234892

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hrmy-20230105.xsd EX-101.SCH 3257
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrmy-20230105_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrmy-20230105_pre.xml EX-101.PRE 22379
8 EXTRACTED XBRL INSTANCE DOCUMENT tm232529d1_8k_htm.xml XML 3628
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 23515703
SIC: 2834 Pharmaceutical Preparations